AeroLeads people directory · profile
Art Polk Email & Phone Number
Head, Corporate Development (Pharmaceutical and Biotech and AI)
at
PacBio
2 work emails found
@petdx.com
4 phones found area 847
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Head, Corporate Development (Pharmaceutical and Biotech and AI)
Location
New York, New York, United States
Who is Art Polk? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Art Polk is listed as Head, Corporate Development (Pharmaceutical and Biotech and AI) at PacBio, based in New York, New York, United States. AeroLeads shows a work email signal at petdx.com, phone signal with area code 847, and a matched LinkedIn profile for Art Polk.
Art Polk previously worked as Chief Financial Officer at Galatea Bio Inc. and Fractional Consultant & Advisor at Polk Expeditions. Art Polk holds Master Of Business Administration - Mba, Healthcare Management from The Wharton School.
Company email context
Email format at PacBio
This section adds company-level context without repeating Art Polk's masked contact details.
{first_initial}{last}@petdx.com
89% confidence
AeroLeads found 2 current-domain work email signals for Art Polk. Compare company email patterns before reaching out.
Profile bio
About Art Polk
Executive CFO/CAO/COO, Corporate Development, investor relations and investment professional across Technology/SaaS, Tools and Diagnostics, Digital Health, Life Sciences, Biotechnology/Pharmaceuticals and Animal Health. - $250M+ in private financings across venture/PE (inception, JV, Series A - Series D)- $500M+ in strategic transactions and M&ASan Diego Business Journal (SDBJ) - 2022 CFO of the Year - Finalist
Listed skills include Financial Analysis, Financial Modeling, Leadership, Business Strategy, and 12 others.
Current workplace
Art Polk's current company
Company context helps verify the profile and gives searchers a useful next step.
9 roles
Art Polk work experience
A career timeline built from the work history available for this profile.
Chief Financial Officer
CurrentF/Prime Capital (Fidelity), Stanford University, and Chan-Zuckerberg Biohub biopharma, clinical genomics, and data platform spinnout focused on addressing large- scale cohort diversity and health equity in precision medicine. Founded and led by by world-renowned population geneticist and Stanford professor Carlos Bustamante, MS, PhD. Investors also include.
Jul 2022 - Present
Fractional Consultant & Advisor
Current- Stealth / Seed - Combination siRNA (CNS) Therapeutics (Academic Lab Spinout)- mi:RNA Diagnostics / Series A - Veterinary Molecular Diagnostics- unPLUG Dining / Seed - AI-enabled restaurant technology platform- Stealth / Seed - CRISPR Therapeutics / Quantitative Drug Discovery Platform- Stealth / Series B - Cell Therapeutics and Manufacturing Platform.
Jan 2023 - Present
Principal
CurrentSpecialist early- to growth stage Animal Health and Petcare venture firm. Focus Areas: Therapeutics | Diagnostics | Petcare | Veterinary Services | Consumer | Pet Food
Mar 2024 - Present
Interim- Chief Operating Officer
Pioneering a novel portfolio of biotherapeutics for diseases of immunologic dysregulation in animals.
Aug 2023 - Jun 2024
Co-Founder, Chief Financial Officer, Head Of Corporate Development
First-in-class next-generation sequencing (NGS) multi-cancer early detection (MCED) liquid biopsy platform for companion animals (veterinary medicine diagnostics). Founded and led by Dr. Daniel Grosu, former Chief Medical Officer of Illumina and Sequenom (acq. LabCorp). Investors included Longview (Crown), Declaration Partners, Torch Capital, Valor Equity.
Apr 2019 - Jul 2023
Life Sciences & Biopharma Investments
Due diligence, business & financial analysis, investment memo development across Life Sciences and High Technology sectors.
Oct 2017 - Dec 2021
Management Consultant (Healthcare Institutions)
U.S. Health system, Medical Group, Payor and Provider engagements spanning strategic planning, M&A, restructuring, and valuation advisory. Focus on health equity and value based care models.
Jan 2018 - Jul 2019
Summer Intern
May 2016 - Aug 2016
4 education records
Art Polk education
Master Of Business Administration - Mba, Healthcare Management
The Wharton School
Bachelor Of Business Administration - Bba
University Of Wisconsin-Madison
Semestre D'Echange - Mim
Escp Business School
Education record
Stevenson High School, Lincolnshire, Il
FAQ
Frequently asked questions about Art Polk
Quick answers generated from the profile data available on this page.
What company does Art Polk work for?
Art Polk works for PacBio.
What is Art Polk's role at PacBio?
Art Polk is listed as Head, Corporate Development (Pharmaceutical and Biotech and AI) at PacBio.
What is Art Polk's email address?
AeroLeads has found 2 work email signals at @petdx.com for Art Polk at PacBio.
What is Art Polk's phone number?
AeroLeads has found 4 phone signal(s) with area code 847 for Art Polk at PacBio.
Where is Art Polk based?
Art Polk is based in New York, New York, United States while working with PacBio.
What companies has Art Polk worked for?
Art Polk has worked for Pacbio, Galatea Bio Inc., Polk Expeditions, Vetted Capital, and Torigen, Inc..
How can I contact Art Polk?
You can use AeroLeads to view verified contact signals for Art Polk at PacBio, including work email, phone, and LinkedIn data when available.
What schools did Art Polk attend?
Art Polk holds Master Of Business Administration - Mba, Healthcare Management from The Wharton School.
What skills is Art Polk known for?
Art Polk is listed with skills including Financial Analysis, Financial Modeling, Leadership, Business Strategy, Private Equity, Commercial Real Estate, Market Research, and Research.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial